Titlebook: Computational Modeling of Drugs Against Alzheimer’s Disease; Kunal Roy Book 2023Latest edition The Editor(s) (if applicable) and The Autho

戲弄

書目名稱Computational Modeling of Drugs Against Alzheimer’s Disease影響因子(影響力)




書目名稱Computational Modeling of Drugs Against Alzheimer’s Disease影響因子(影響力)學科排名




書目名稱Computational Modeling of Drugs Against Alzheimer’s Disease網(wǎng)絡公開度




書目名稱Computational Modeling of Drugs Against Alzheimer’s Disease網(wǎng)絡公開度學科排名




書目名稱Computational Modeling of Drugs Against Alzheimer’s Disease被引頻次




書目名稱Computational Modeling of Drugs Against Alzheimer’s Disease被引頻次學科排名




書目名稱Computational Modeling of Drugs Against Alzheimer’s Disease年度引用




書目名稱Computational Modeling of Drugs Against Alzheimer’s Disease年度引用學科排名




書目名稱Computational Modeling of Drugs Against Alzheimer’s Disease讀者反饋




書目名稱Computational Modeling of Drugs Against Alzheimer’s Disease讀者反饋學科排名

Indolent

Recent Advances in Computational Modeling of BACE1 Inhibitors as Anti-Alzheimer Agentsdefined by progressive neuronal death and synaptic loss in the human brain and can be brought on by both genetic and environmental risk factors. The beta-site amyloid precursor protein (APP) cleaving enzyme 1 (BACE1) is the major beta secretase for the generation of amyloid-β peptides in the neurons

租約

枯燥

certitude

Computer-Assisted Drug Design: A Toolbox for Novel Tau Kinase Inhibitors and Its Implications in Alzies in proteins, responsible for regulating normal cellular metabolism. However, a slight imbalance in the kinase signaling pathways leads to hyperphosphorylation of the residues, resulting in pathological disorders eventually leading to neurodegenerative diseases. Therefore, the design of scaffolds

恭維

Computational Modeling Approaches in Search of Anti-Alzheimer’s Disease Agents: Case Studies of Phos messengers: cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). Due to the high expression of various PDE subfamilies in the human brain, PDE inhibition has a substantial impact on neurodegenerative diseases by controlling the level of cAMP or cGMP. In this regard, seve

恭維

Recent Advances in Computational Modeling of Multi-targeting Inhibitors as Anti-Alzheimer Agentsnges. It is highly prevalent in the elderly, with a constantly growing number of new cases worldwide. In affluent nations with aging populations, AD has been a major source of economic and social problems. As a result, the discovery of novel treatment methods for this disease is now crucial. With ad

Priapism

灌輸

Computational Modeling of DYRK1A Inhibitors as Potential Anti-Alzheimer Agents, especially Alzheimer’s disease (AD). In this chapter, different ligand-based and structure-based computational approaches were explored to develop a workflow for the selection of potential candidates as inhibitors of DYRK1A. The NuBBE database—comprising different compounds from the Brazilian biod

捕鯨魚叉